X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Key excerpts: PhRMA submits comments to keep the six protected classes protected

By Tom Wilbur  |    February 19, 2021
Earlier this month, PhRMA submitted comments to CMS regarding the Part D Payment Modernization Model Request for Applications (RFA) for calendar year 2022. This RFA was released on January 19,...   Read More

Action needed to preserve the six protected classes

By Tom Wilbur  |    February 3, 2021
In the final hours of the previous Administration’s time in office, the Center for Medicare & Medicaid Innovation (the Innovation Center) (CMMI) announced new changes for CY 2022 to an existing...   Read More

End of year Part D reading List

By Tom Wilbur  |    December 18, 2020
Happy Holidays, Part D readers, and thank you for following along this year as we explored the impact of Medicare Part D and the important role the program plays for seniors and those with...   Read More

New analysis finds stark difference in coverage of breast cancer medicines for seniors in the United States and England

By Nicole Longo  |    December 10, 2020
In the United States, seniors and people with disabilities enjoy broad coverage of physician-administered medicines under Medicare Part B because the program relies on market competition to...   Read More

Final rebate rule represents right way to change Medicare

By Tom Wilbur  |    December 1, 2020
As Washington policymakers look to make changes to Medicare and our health care system overall, there are right ways and wrong ways to address the challenges that seniors and patients face....   Read More

No matter how you look at it, the Most Favored Nation rule is bad policy

By Nicole Longo  |    December 1, 2020
Last month, the administration released the “Most Favored Nation” (MFN) rule, which allows foreign governments to decide the value of Part B medicines, while also likely limiting seniors’ access...   Read More

Open Enrollment: How to find a Medicare plan that meets your needs

By Tom Wilbur  |    October 14, 2020
Medicare’s annual open enrollment period is right around the corner. In fact, beginning October 15 and running through December 7, newly qualified patients and current Medicare beneficiaries may...   Read More

Three reasons why repealing the Part D non-interference clause is a bad idea

By Tom Wilbur  |    October 1, 2020
For more than a decade, Medicare Part D has provided seniors affordable and comprehensive prescription drug coverage. Its unique, market-based structure has kept overall Part D program costs far...   Read More

Supporting access to vaccines for Part D beneficiaries

By Tom Wilbur  |    August 12, 2020
Today, in honor of National Immunization Awareness Month, we’ll take a look at how Medicare Part D supports access to critical vaccines and strengthens public health. Vaccines represent some of...   Read More

Medicare’s 55th anniversary: Celebrating the success of Part D

By Tom Wilbur  |    July 30, 2020
Today, we are excited to bring you a special edition of our Medicare Catalyst series in honor of Medicare’s 55th anniversary. On this date in 1965, President Lyndon B. Johnson signed into law...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates